medline.ch Neurologie Multiple Sklerose

	Rising burden and future projections of multiple sclerosis in East Asia: Findings from the global burden of disease study 2021. Mult Scler Relat Disord Liu W, Liu P, Wang Q, Li X. PMID: 42398276 [PubMed - as supplied by publisher]
	UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance. Mult Scler Mullan G, Ford HL, Blackall P, Bongol D, Bonham N, Brex P, Hoyle N, Murray K, Nelson-Piercy C, Pearson OR, Rog D, Prinja P, Dobson R. PMID: 42397849 [PubMed - as supplied by publisher]
	Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study. Neurol Ther Suntah AM, Hecker M, Barhoum B, Langenberger JE, Baldt J, Streckenbach B, Richter J, Frahm N, Heidler F, Zettl UK. PMID: 42397473 [PubMed - as supplied by publisher]
	Assistive device prescriptions in multiple sclerosis: a cross-sectional study of disability distribution. Disabil Rehabil Assist Technol Chiaramonte R, Vecchio M, Di Benedetto P, Longo L, Leonforte F, Mistretta A, Laganga Senzio G, Civello T. PMID: 42396771 [PubMed - as supplied by publisher]
	Multiple sclerosis and the limits of classical autoimmune theory. Front Immunol Hedström AK, Piehl F. PMID: 42396441 [PubMed - indexed for MEDLINE]
	Reproductive, Dietary, and Physical Activity Factors Associated With Multiple Sclerosis: A Case-Control Study. Health Sci Rep Razazian N, Bashiri S, Aliahmadi A, Eskandarieh S, Sahraian MA, MohamadYari M, Rezaei M, Fakhri N. PMID: 42394741 [PubMed]
	Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study. Cent Nerv Syst Agents Med Chem Yadav A, Kaushik N, Paliwal D, Thakur A, Maurya A, Sahu R. PMID: 42393898 [PubMed - as supplied by publisher]
	Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation. Neurol Sci Hammadeh BM, Sameer S, Alnajjar M, Abu-Issa I, Alhallaq MS, Ghazi M, Badr A, Shawawrah M. PMID: 42393408 [PubMed - indexed for MEDLINE]
	Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis. J Neurol Sci Guo M, Liu H, Han J. PMID: 42391748 [PubMed - as supplied by publisher]
	The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review. J Neurol Koks F, Reubens F, van der Zee H, Briedé JJ. PMID: 42390760 [PubMed - indexed for MEDLINE]
	Effects of Technology-Based Perturbation Training During Walking on Physical Function in Stroke, Multiple Sclerosis, and Parkinson's Disease: A Scoping Review. NeuroRehabilitation Lahtio H, Kulmala R, Saastamoinen L, Suikkanen S, Rintala A. PMID: 42390369 [PubMed - as supplied by publisher]
	Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis. bioRxiv Mounts K, Liu Y, Fujita M, Oyegunle J, Neziraj T, Pollak SV, Nandakumar R, Ngouth N, Steele SU, Cortese I, White CC, Jacobson S, Reich DS, De Jager PL. PMID: 42388799 [PubMed]
	Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis. J Neurol Aratake Y, Yoshinaga K, Ashida S, Fujii C, Hamatani M, Kimura K, Ochi H, Takahashi R, Kondo T. PMID: 42387037 [PubMed - indexed for MEDLINE]
	Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study. J Neurol Neurosurg Psychiatry Maunula A, Laakso SM, Viitala M, Sumelahti ML, Atula S. PMID: 42386505 [PubMed - as supplied by publisher]
	Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study. Mult Scler Relat Disord Cabañas Engenios G, Mena García N, Garay Albízuri P, Llanes Ferrer A, Sánchez Asensio A, Romero Ferro J, Gil Martinez L, Campos Jiménez M, Pastor González R, Rodríguez Jorge F, Sainz De La Maza S, Monreal Laguillo E, Villar LM, Masjuan Vallejo J, Costa-Frossard L, Chico García JL. PMID: 42385519 [PubMed - as supplied by publisher]
	Advances in Multiple Sclerosis. N Engl J Med Hauser SL. PMID: 42384871 [PubMed - indexed for MEDLINE]
	Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis. N Engl J Med Torkildsen Ø, Brustad HK, Høgestøl EA, Alstadhaug KB, Bhan A, Flemmen HØ, Habbestad A, Høglund RAA, LeBlanc M, Lopen P, Lorentzen ÅR, Morsund ÅH, Lossius A, Lundby R, Nygaard GO, Rød BE, Simonsen CS, Steffensen L, Torgauten H, Piehl F, Wergeland S, Myhr KM, OVERLORD-MS Investigators. PMID: 42384870 [PubMed - indexed for MEDLINE]
	Exploring attitudes and acceptance of artificial intelligence in multiple sclerosis from the patient perspective. PLOS Digit Health Inojosa H, Masanneck L, Voigt I, Schriefer D, von Horsten N, Wenk J, Gasparovic-Curtini I, Haase R, Meuth SG, Huttner HB, Gilbert S, Pawlitzki M, Ziemssen T. PMID: 42384671 [PubMed]
	T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis. Immunotargets Ther Egba SI, Ikechukwu GC, Okereke CI, Orhonigbe IO, Uroko RI, Ugwu OPC. PMID: 42383100 [PubMed]
	Multiple sclerosis patients under treatment with interferon Î²1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine. Front Immunol Liotti A, Maniscalco GT, Ferrara AL, Mazzone V, Dehbozorgi M, Szabó A, Belardo M, Marcogiuseppe D, De Martino A, Di Battista ME, Servillo G, Moreggia O, Di Giulio Cesare D, Andreone V, Varricchi G, De Rosa V. PMID: 42382741 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 44392

Seite 1 von 2220

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung